Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Implantable Brain-Computer Interface for Upper-Limb Recovery After Stroke

NCT: NCT07477613 · RECRUITING

NCT IDNCT07477613
StatusRECRUITING
Start Date2026-04-08
Completion2031-04-08
SponsorUniversity Hospital, Grenoble (OTHER)
First posted
Last updated

Brief Summary

The clinical investigation will take place in three phases: * A pre-selection/selection phase to ensure that the patient (lesion, symptoms, ability of our tools to detect your movement intentions, etc.) is suitable for a six-month intensive rehabilitation program using Brain-Machine Interface. * A second phase, consisting of implementing the intensive rehabilitation program, first in the traditional manner, without the Brain-Machine Interface (2 to 5 weeks), then, after implantation, with the Brain-Machine Interface (6 months). * During the third phase, only follow-up visits will be scheduled to ensure the longevity of the implants and the maintenance of the motor progress achieved through rehabilitation.

Frequently Asked Questions

What is Implantable Brain-Computer Interface for Upper-Limb Recovery After Stroke?

Implantable Brain-Computer Interface for Upper-Limb Recovery After Stroke is a clinical trial registered under NCT07477613. Current status: RECRUITING.

What is the status of NCT07477613?

The current status of NCT07477613 (Implantable Brain-Computer Interface for Upper-Limb Recovery After Stroke) is: RECRUITING.

When did Implantable Brain-Computer Interface for Upper-Limb Recovery After Stroke start?

Implantable Brain-Computer Interface for Upper-Limb Recovery After Stroke started on 2026-04-08.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.